CytomX Therapeutics (CTMX)
CytomX Therapeutics (CTMX) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- CTMX last traded at $2.04 on 2026-11-20, -0.34% for the session.
- CytomX Therapeutics: market cap $445.41M, revenue $14.03M over the last four quarters.
- Over the past year CTMX returned -43.72%, with a year-to-date return of -52.04%.